These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3567061)

  • 1. Liver tumour blood flow and responses to arterial embolization measured by dynamic hepatic scintigraphy.
    Flowerdew AD; McLaren MI; Fleming JS; Britten AJ; Ackery DM; Birch SJ; Taylor I; Karran SJ
    Br J Cancer; 1987 Mar; 55(3):269-73. PubMed ID: 3567061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in arterial and portal perfusion in embolized and nonembolized hepatic lobes after portal vein embolization evaluated by helical computed tomography.
    Wakabayashi H; Nakano S; Ishimura K; Hagiike M; Okano K; Maeba T; Maeta H
    Surg Today; 2001; 31(11):991-5. PubMed ID: 11766087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of Doppler perfusion index changes in patients with colorectal cancer liver metastases.
    Kopljar M; Brkljacic B; Doko M; Horzic M
    J Ultrasound Med; 2004 Oct; 23(10):1295-300. PubMed ID: 15448318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doppler sonography of hepatic arterial blood flow velocity after percutaneous transhepatic portal vein embolization.
    Kito Y; Nagino M; Nimura Y
    AJR Am J Roentgenol; 2001 Apr; 176(4):909-12. PubMed ID: 11264076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Portal vein embolization: Present and future].
    Piron L; Deshayes E; Escal L; Souche R; Herrero A; Pierredon-Foulongne MA; Assenat E; le Lam N; Quenet F; Guiu B
    Bull Cancer; 2017 May; 104(5):407-416. PubMed ID: 28477870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver angioscintigraphy: clinical applications.
    Dragoteanu M; Cotul SO; Pîgleşan C; Tamaş S
    Rom J Gastroenterol; 2004 Mar; 13(1):55-63. PubMed ID: 15054528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple collaterals to hepatic infantile hemangioendotheliomas and arteriovenous malformations: effect on embolization.
    Fellows KE; Hoffer FA; Markowitz RI; O'Neill JA
    Radiology; 1991 Dec; 181(3):813-8. PubMed ID: 1947103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in hepatic parenchymal blood flow with colorectal metastases: increase in arterial and decrease in portal blood flow.
    Kunishima S; Taniguchi H; Yamaguchi A; Koh T; Yamagishi H
    Hepatogastroenterology; 2003; 50(53):1457-62. PubMed ID: 14571763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of octreotide infusion on hepatic and tumour blood flow in two experimental models of liver metastases.
    Davies N; Kynaston H; Yates J; Nott DM; Taylor BA; Jenkins SA
    Eur J Gastroenterol Hepatol; 1995 Oct; 7(10):971-4. PubMed ID: 8590143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of hepatic functional parameters with changes of functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization: a follow-up report.
    Nanashima A; Tobinaga S; Abo T; Sumida Y; Araki M; Hayashi H; Sakamoto I; Kudo T; Takeshita H; Hidaka S; Sawai T; Hatano K; Nagayasu T
    J Surg Res; 2010 Dec; 164(2):e235-42. PubMed ID: 20869076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis.
    Leen E; Goldberg JA; Anderson JR; Robertson J; Moule B; Cooke TG; McArdle CS
    Gut; 1993 Apr; 34(4):554-7. PubMed ID: 8491406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases.
    Spelt L; Sparrelid E; Isaksson B; Andersson RG; Sturesson C
    HPB (Oxford); 2015 Jun; 17(6):529-35. PubMed ID: 25726854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic hypertrophy and hemodynamics of portal venous flow after percutaneous transhepatic portal embolization.
    Shimada S; Kamiyama T; Yokoo H; Orimo T; Wakayama K; Nagatsu A; Kakisaka T; Kamachi H; Abo D; Sakuhara Y; Taketomi A
    BMC Surg; 2019 Feb; 19(1):23. PubMed ID: 30777042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in vascularity of liver tumours after hepatic arterial embolization with degradable starch microspheres.
    Civalleri D; Scopinaro G; Balletto N; Claudiani F; De Cian F; Camerini G; DePaoli M; Bonalumi U
    Br J Surg; 1989 Jul; 76(7):699-703. PubMed ID: 2765804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood supply of liver metastatic tumors observed by both CT arterial portography via superior mesenterica arterial and multi-slice spiral CT perfusion imaging].
    Shi GF; Wang Q; Li ZG; Wang SJ; DU Y; Wang YN
    Ai Zheng; 2007 Nov; 26(11):1257-62. PubMed ID: 17991329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective portal vein embolization as introduction in major surgery.
    Matela J; Zabavnik Z; Jukić T; Jukić D; Glavina K; Tusek-Bunc K; Pavan-Jukić D
    Coll Antropol; 2005 Jun; 29(1):163-7. PubMed ID: 16117317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of temporary occlusion of the hepatic vein on dual blood in the liver: evaluation with spiral CT.
    Murata S; Itai Y; Asato M; Kobayashi H; Nakajima K; Eguchi N; Saida Y; Kuramoto K; Tohno E
    Radiology; 1995 Nov; 197(2):351-6. PubMed ID: 7480676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of preoperative embolization of the right portal vein and hepatic artery prior to major hepatectomy in high-risk patients: a preliminary report.
    Inaba S; Takada T; Amano H; Yoshida M; Yamakawa Y; Yasuda H; Takada Y; Takeshita K; Koutake H; Takada K; Furui S; Hijikata H; Takada K
    Hepatogastroenterology; 2000; 47(34):1077-81. PubMed ID: 11020883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative selective portal vein embolization (PSPVE) before major hepatic resection. Effectiveness of Doppler estimation of hepatic blood flow to predict the hypertrophy rate of non-embolized liver segments.
    Gerunda GE; Bolognesi M; Neri D; Merenda R; Miotto D; Barbazza F; Zangrandi F; Bisello M; Valmasoni M; Gangemi A; Gagliesi A; Faccioli AM
    Hepatogastroenterology; 2002; 49(47):1405-11. PubMed ID: 12239952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of sandostatin (Octreotide, SMS 201-995) infusion on splanchnic and hepatic blood flow in an experimental model of hepatic metastases.
    Hemingway DM; Jenkins SA; Cooke TG
    Br J Cancer; 1992 Mar; 65(3):396-8. PubMed ID: 1558793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.